Zouzoulas, D.; Tsolakidis, D.; Tzitzis, P.; Chatzistamatiou, K.; Theodoulidis, V.; Sofianou, I.; Grimbizis, G.; Timotheadou, E.
CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study. Int. J. Mol. Sci. 2024, 25, 5230.
https://doi.org/10.3390/ijms25105230
AMA Style
Zouzoulas D, Tsolakidis D, Tzitzis P, Chatzistamatiou K, Theodoulidis V, Sofianou I, Grimbizis G, Timotheadou E.
CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study. International Journal of Molecular Sciences. 2024; 25(10):5230.
https://doi.org/10.3390/ijms25105230
Chicago/Turabian Style
Zouzoulas, Dimitrios, Dimitrios Tsolakidis, Panagiotis Tzitzis, Kimon Chatzistamatiou, Vasilis Theodoulidis, Iliana Sofianou, Grigoris Grimbizis, and Eleni Timotheadou.
2024. "CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study" International Journal of Molecular Sciences 25, no. 10: 5230.
https://doi.org/10.3390/ijms25105230
APA Style
Zouzoulas, D., Tsolakidis, D., Tzitzis, P., Chatzistamatiou, K., Theodoulidis, V., Sofianou, I., Grimbizis, G., & Timotheadou, E.
(2024). CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study. International Journal of Molecular Sciences, 25(10), 5230.
https://doi.org/10.3390/ijms25105230
